Overview

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the benefits of combination niacin ER/lovastatin in patients receiving standard care who are not at LDL goal per ATP III guidelines.
Phase:
Phase 4
Details
Lead Sponsor:
In His Image
Collaborator:
Kos Pharmaceuticals
Treatments:
Dihydromevinolin
Hydroxymethylglutaryl-CoA Reductase Inhibitors
L 647318
Lovastatin
Niacin
Niacinamide
Nicotinic Acids